In HF patients, NOX2 is upregulated in coronary endothelial cells and not in cardiomyocytes, focusing on the role of microvascular dysfunction as primum movens in the pathological alteration and cardiac remodeling in HF [37,44]. This evidence concerns the gene CYBB and hydrops fetalis.